Vedana Therapeutics
PrivateLast Round
Series A
Jun 17, 2026
Total Funding Raised
$46M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vedana Therapeutics is a biotechnology company that develops next-generation therapies for migraine prevention.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vedana Therapeutics Comparables
Compare Vedana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Slate Medicines | 94% | |
| DartsBio Pharmaceutical (Guangdong) Co., Ltd. | 78% | |
| H. Lundbeck A/S | 71% |
Vedana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 17, 2026 |
Vedana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
$46M round led by Canaan Partners and Westlake Village Biopartners.
Vedana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vedana Therapeutics's valuation, stock price, and market status.
Is Vedana Therapeutics a public or private company?
Vedana Therapeutics is a private company.
What is the current stock price of Vedana Therapeutics?
Vedana Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Vedana Therapeutics worth (valuation)?
Valuation information for Vedana Therapeutics is not publicly available.
Can I buy Vedana Therapeutics stock?
Vedana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vedana Therapeutics's last funding round?
Vedana Therapeutics's most recent funding round was Series A on June 17, 2026.
Who are the main investors in Vedana Therapeutics?
Key investors in Vedana Therapeutics include Westlake Village Biopartners, Canaan Partners.
Will Vedana Therapeutics IPO soon?
No public IPO plans have been announced for Vedana Therapeutics.
How can I track Vedana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vedana Therapeutics's secondary market activity and sign up for updates.